Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Terrapin and Pharmagene enter drug screening alliance

Nov. 28, 1997

Genetronics cleared to start electroporation therapy phase II trial in U.S.

Nov. 27, 1997

Electroporation for gene delivery into tumor cells: in vivo results

Nov. 26, 1997

Myriad Genetics and Bayer join forces to develop dementia and depression therapies

Nov. 24, 1997

Pharmacopeia/Texas Biotechnology drug discovery collaboration

Nov. 21, 1997

Notice of allowance issued for DepoTech's drug delivery patent

Nov. 21, 1997

Andrx seeks patent coverage for new drug delivery system

Nov. 20, 1997

Sankyo and ArQule enter drug discovery collaboration

Nov. 19, 1997

LXR's patented drug screening technology yields two novel apoptosis-suppressing agents

Nov. 18, 1997

Second drug from Inhale/Baxter collaboration enters clinical testing

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...